Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128736) titled 'Efficacy of Repeat Dosing of Liposomal Bupivacaine on Postoperative Pain in Patients with Anal Fistula: A Multicenter, Randomized, Open-Label, Controlled Study' on July 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Sixth Affiliated Hospital of Sun Yat-sen University
Condition:
Anal Fistula
Intervention:
Liposomal Bupivacaine Repeat Dosing Group:A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.
Recruitment Status: Not Recruiting
Phase: N/A
Date of ...